🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Transthyretin Amyloidosis With Cardiomyopathy

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis NCT07695701Phase 41 site📍 St Louis Eidos Therapeutics, a BridgeBio company · Tests: Acoramidis (AG10) oral tablet A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites📍 Multiple Locations📍 Multiple Locations📍 Multiple Locations Bayer · Tests: Acoramidis (356 mg film-coated tablets) Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation NCT06813443n/a3 sites📍 Bologna📍 Roma📍 Florence IRCCS Azienda Ospedaliero-Universitaria di Bologna An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy NCT06907186NA1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: Psychological Support Hungarian National Systemic Amyloidosis Registry NCT07689331n/a12 sites📍 Balatonfüred📍 Budapest📍 Budapest Semmelweis University A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. NCT07448623Phase 11 site📍 Groningen Novo Nordisk A/S · Tests: Coramitug Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations NCT07654855n/a6 sites📍 Los Angeles📍 Vancouver📍 Beijing AstraZeneca · Tests: None ( observational study ) US Benchmarking Clinical Study NCT07215715n/a3 sites📍 Boston📍 Boston📍 Boston eMyosound SAS Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy NCT07791160n/a1 site📍 Many Locations Bayer · Tests: Acoramidis PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY NCT05098665NA1 site📍 London Richmond Research Institute · Tests: Telemonitoring service MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) NCT06128629Phase 3132 sites📍 Tucson📍 Los Angeles📍 Los Angeles Intellia Therapeutics · Tests: NTLA-2001, Placebo Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy NCT07240844Phase 42 sites📍 Seoul📍 Seoul Seoul St. Mary's Hospital · Tests: Enavogliflozin 0.3mg, Placebo A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact. NCT06836011n/a8 sites📍 Graz📍 Vienna📍 Munich Medical University of Vienna A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis NCT07298044Phase 426 sites📍 Sankt Pölten📍 Vienna📍 Vienna Bayer · Tests: Acoramidis DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting NCT07358078n/a27 sites📍 Tucson📍 Beverly Hills📍 La Jolla Alnylam Pharmaceuticals CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis NCT07207811Phase 3299 sites📍 Phoenix📍 La Jolla📍 Los Angeles Novo Nordisk A/S · Tests: NNC6019-0001, Placebo (NNC6019-0001) TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy NCT07052903Phase 3266 sites📍 La Jolla📍 Laguna Hills📍 Stanford Alnylam Pharmaceuticals · Tests: Nucresiran, Sterile Normal Saline (0.9% NaCl) Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study NCT07196839n/a1 site📍 Dallas University of Texas Southwestern Medical Center Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) NCT06318260Phase 1, Phase 21 site📍 Aarhus Steen Hvitfeldt Poulsen · Tests: Dobutrex
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy